Oblique Therapeutics AB (publ.) logo — Antibody Magic

Oblique Therapeutics AB (publ.)

Antibody Magic

Founded 2015 Sweden Sweden 17 employees Venture round Total: $2.50M Biotechnology, Health Care +1

General Information

Company Name Oblique Therapeutics AB (publ.)
Founded Year 2015
Location Sweden Sweden
Founders / Decision Makers
Team member
Employees 17
Industries Biotechnology, Health Care, Pharmaceutical
Funding Stage Venture round
Social

BounceWatch is an independent company data service, not affiliated with Oblique Therapeutics AB (publ.). To contact Oblique Therapeutics AB (publ.), visit obliquet.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

About Oblique Therapeutics AB (publ.)

Oblique Therapeutics is a Swedish-based biotech company founded in 2015, dedicated to developing revolutionary pharmaceuticals addressing severe illnesses with unmet medical needs, with a particular focus on advanced cancer and pain. The company received a $2.50M Venture Round investment on 11 December 2015 from Almi Invest. Oblique Therapeutics operates within the Biotechnology, Health Care, and Pharmaceutical industries, with its headquarters located in Sweden. The company’s mission is to introduce groundbreaking treatments that meet the unaddressed medical requirements in severe illness, making it an attractive prospect for venture capital investments.

Taxonomy: Swedish-based, biotech company, Oblique Therapeutics, pharmaceuticals, severe illnesses, advanced cancer, pain, drug development, medical requirements, innovative treatments

Funding Rounds & Investors (1)

View All
Funding Stage Amount Investors Lead Investors Date
Venture Round $2.50M 1
Almi Invest
11 Dec 2015

Oblique Therapeutics AB (publ.) Alternatives & Competitors

View All Alternatives
Oblique Therapeutics AB (publ.) vs

Pre-clinical stage biotech company developing an antibody immunotherapy drug for cancer using an “In...

Angel
1 employees
Biotechnology, Health Care
Oblique Therapeutics AB (publ.) vs

Kolltan, a privately held clinical-stage company, is focused on advancing a new generation of therap...

Series D
8 employees
Biotechnology, Pharmaceutical
Oblique Therapeutics AB (publ.) vs
MAX BioPharma, Inc.
MAX BioPharma, Inc. United States

Pioneering new treatments for severe and life-threatening illnesses through innovative small molecul...

12 employees
Biopharma, Biotechnology

FAQ About Oblique Therapeutics AB (publ.)

Antibody Magic
Oblique Therapeutics AB (publ.) was founded in 2015.
Oblique Therapeutics AB (publ.) is headquartered in Sweden.
Oblique Therapeutics AB (publ.) operates in Biotechnology, Health Care and Pharmaceutical. Its work centres on Swedish-based, biotech company, Oblique Therapeutics and pharmaceuticals.
Oblique Therapeutics AB (publ.) has approximately 17 employees.
Oblique Therapeutics AB (publ.) has completed 1 funding round, raising a total of $2.50M. The latest funding stage is Venture round.
Top alternatives and competitors to Oblique Therapeutics AB (publ.) include Novelogics Biotechnology Inc., Kolltan Pharmaceuticals, Inc., MAX BioPharma, Inc., Sciwind Biosciences, Biomed Valley Discoveries. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Oblique Therapeutics AB (publ.) and Novelogics Biotechnology Inc. are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Oblique Therapeutics AB (publ.), https://bouncewatch.com/company/oblique-therapeutics, updated 24 October 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes